2016年5月， 中南大学湘雅二医院 在OncoTargets and Therapy（IF2.7001/4区）期刊上发表了一篇论文。在 发表9年后 ，因 图片组内重复 在pubpeer上被读者质疑。
To elucidate the mechanism further, HepG2 cells were treated with an adenosine monophosphate-activated protein kinase (AMPK) inhibitor to test whether SOX9 acts via AMPK activation. SOX9 ...
Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback